Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 41 742.9 |
96 | EP file number | EAKZ | 01 92 3265.1 |
86 | WO file number | WAKZ | PCT/US01/40069 |
97 | EP publication number | EPN | 1254237 |
87 | WO publication number | WPN | 2001059078 |
54 | Designation/title | TI | AGGREGAT-FREIE HARNSÄUREOXIDASE ZUR HERSTELLUNG VON NICHT-IMMUNOGENEN POLYMER-KONJUGATEN |
51 | IPC main class | ICM (ICMV) | C12N 15/53 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 9/06 (2006.01), C12N 9/96 (2006.01), A61K 38/44 (2006.01), A61K 47/50 (2017.01) |
22 | DE application date | DAT | Feb 7, 2001 |
96 | EP application date | EAT | Feb 7, 2001 |
86 | WO application date | WAT | Feb 7, 2001 |
43 | Date of first publication | OT | Aug 16, 2001 |
| Date of publication of grant | PET | Apr 7, 2010 |
71/73 | Applicant/owner | INH | Duke University Office of Licensing and Ventures, Durham, N.C., US; Mountain View Pharmaceuticals, Inc., Menlo Park, Calif., US |
72 | Inventor | IN | SHERMAN, Merry, R., San Carlos, CA 94070, US; SAIFER, Mark, G., San Carlos, CA 94070, US; WILLIAMS, L., David, Fremont, CA 94536, US; HERSHFIELD, Michael, S., Durham, Nort Carolina 27707, US; KELLY, Susan, J., Chapel Hill, North Carolina 27516, US |
74 | Representative | VTR | SSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB, 81829 München, DE |
| Address for service | | SSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB, 81806 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 501730 Feb 10, 2000
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2013 000 058.9 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001254237 Searchable text:
EP000001254237 Original document:
EP000001254237B1 Searchable text:
EP000001254237B1 Original document:
WO002001059078 Searchable text:
WO002001059078 |
43 | Date of first publication | EVT | Aug 16, 2001 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 3, 2023 (Show all update days)(Hide all update days)- Aug 3, 2023; Jun 24, 2023; Jun 22, 2023; Feb 9, 2021; Mar 12, 2020; Aug 13, 2019; Mar 13, 2019; Mar 9, 2019; Oct 22, 2018; Mar 8, 2018; Mar 9, 2017; Mar 11, 2016; Aug 25, 2015; Mar 13, 2015; Mar 11, 2015; Mar 18, 2014; Mar 11, 2014; Sep 24, 2013; Jul 16, 2013; Mar 16, 2013; Mar 12, 2013; Jan 24, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 15, 2013 |
71/73 | Applicant/owner | INH | Duke University Office of Licensing and Ventures, Durham, N.C., US; Mountain View Pharmaceuticals, Inc., Menlo Park, Calif., US |
71/73 | Previous applicant/owner | INHF | Mountain View Pharmaceuticals, Inc., Menlo Park, Calif., US, Duke University, Durham, N.C., US |